Coston, McIsaac & Partners
- SEC CIK
- 0001945037
- Latest filing
- Aug 12, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Coston, McIsaac & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −25−100.0% | Sold out | Holders |
| Q1 2023 | 25 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 25 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 25 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 25 | $2.00K | <0.1% | – | No prior filing | Holders |